RESEARCH PAPER
Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy
1
Clinical Oncology Ward, St. John’s Cancer Center, Lublin, Poland
2
Department of Applied Psychology, Medical University of Lublin, Poland
3
Department for Health Problems of Ageing, Institute of Rural Health in Lublin, Poland
Corresponding author
Ann Agric Environ Med. 2015;22(1):185-189
KEYWORDS
ABSTRACT
Introduction:
Evaluation of the presence of symptoms of anxiety and depression in women treated for breast cancer who underwent surgical procedure using one of two alternative methods, either radical mastectomy or breast conserving treatment (BCT).
Material and Methods:
A questionnaire survey involved 85 patients treated in a conservative way and 94 patients after breast amputation. Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI) and depression degree evaluation questionnaire were used in the study. The patients’ responses were statistically analyzed.
Results:
Based on the HADS questionnaire, the total anxiety level in the group of women treated with BCT was 6.96 points, while in the group of patients who had undergone mastectomy the value was 7.8 points. The observed results were statistically significant. In the case of depression, the following values were found: patients after amputation had 8.04 scale value points, and those after BCT had 6.8 scale value points. The observed differences were statistically significant. Negative correlation was found between the level of anxiety and depression. The total level of depression evaluated using the Beck scale was 16.3 points in the BCT group, which means that they suffered from mild depression, while in the mastectomy group the level was 19.6 points, which corresponds to moderate depression.
Conclusions:
The level of anxiety and depression among women with breast cancer was influenced by the type of the applied surgical procedure and adjuvant chemotherapy. Demographic variables did not influence the level of anxiety and depression.
Evaluation of the presence of symptoms of anxiety and depression in women treated for breast cancer who underwent surgical procedure using one of two alternative methods, either radical mastectomy or breast conserving treatment (BCT).
Material and Methods:
A questionnaire survey involved 85 patients treated in a conservative way and 94 patients after breast amputation. Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI) and depression degree evaluation questionnaire were used in the study. The patients’ responses were statistically analyzed.
Results:
Based on the HADS questionnaire, the total anxiety level in the group of women treated with BCT was 6.96 points, while in the group of patients who had undergone mastectomy the value was 7.8 points. The observed results were statistically significant. In the case of depression, the following values were found: patients after amputation had 8.04 scale value points, and those after BCT had 6.8 scale value points. The observed differences were statistically significant. Negative correlation was found between the level of anxiety and depression. The total level of depression evaluated using the Beck scale was 16.3 points in the BCT group, which means that they suffered from mild depression, while in the mastectomy group the level was 19.6 points, which corresponds to moderate depression.
Conclusions:
The level of anxiety and depression among women with breast cancer was influenced by the type of the applied surgical procedure and adjuvant chemotherapy. Demographic variables did not influence the level of anxiety and depression.
REFERENCES (25)
1.
Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2010 roku. Cancer in Poland in 2010. Warszawa, Centrum Onkologii-Instytut, 2012 (in Polish).
2.
Aebi S, Davidson T, Gruber G, Cardoso F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011; 22(Suppl 6): 12–24.
3.
Association of Breast Surgery at Baso 2009. Surgical guidelines for the management of breast cancer. Eur J Surg Oncol. 2009; 35(Suppl 1): 1–22.
4.
Mosher CE, Johnson C, Dickler M, Norton L, Massie MJ, Duhamel K. Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae. Breast J. 2013; 19(3): 285–292.
5.
Turner J, Kelly B, Swanson C, Allison R, Wetzig N. Psychosocial impact of newly diagnosed advanced breast cancer. Psychooncology 2005; 14(5): 396–407.
6.
Majkowicz M. Wielopoziomowa ocena stanu podmiotowego pacjentów z chorobą nowotworową. Ann Acad Med Ged. 2005; 35(supl 2): 162–163 (in Polish).
7.
Curtis R, Groarke A, McSharry J, Kerin M. Experience of Breast Cancer: Burden, Benefit, or Both? Cancer Nurs. 2013; 10;8(7): 68753.
8.
Dziemidok P, Makara-Studzińska M, Jarosz MJ. Diabetes and depression: a combination of civilization and life-style diseases is more than simple problem adding – literature review. Ann Agric Environ Med. 2011; 18(2): 318–322.
9.
Majkowicz M, Chojnacka-Szawłowska G. Metodologiczne problemy badania jakości życia. In: de Walden-Gałuszko K, Majkowicz M. Jakość życia w chorobie nowotworowej. Gdańsk, Wydawnictwo Uniwersytetu Gdańskiego, 1994.p. 65–81 (in Polish).
10.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67(6): 361–370.
11.
Mielcarek P, Kozacka J. Funkcjonowanie emocjonalne chorych z objawami niepowodzenia chemioterapii zaawansowanego raka jajnika. Psychoonkol. 2006; 10(1): 9–14 (in Polish).
12.
Beck AT, Guthy D, Steer RA, Ball R. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984; 40: 1365–1367.
13.
Meisel JL, Domchek SM, Vonderheide RH, Giobbie-Hurder A, Lin NU, Winer EP, et al. Quality of life in long-term survivors of metastatic breast cancer. Clin Breast Cancer. 2012; 12(2): 119–126.
14.
Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M. Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol. 2010; 27(1): 108–113.
15.
Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y. Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol. 2004; 22(10): 1957–1965.
16.
Reece JC, Chan YF, Herbert J, Gralow J, Fann JR. Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer. Gen Hosp Psychiatry. 2013; 35(4): 376–381.
17.
Khademi A, Alleyassin A, Aghahosseini M, Ramezanzadeh F, Abhari AA. Pretreatment Beck Depression Inventory score is an important predictor for post- treatment score in infertile patients: a before- after study. BCM Psychiatry. 2005; 5: 26.
18.
Nowicki A, Rządkowska B. Depresja i lęk u chorych z nowotworami złośliwymi. Wsp Onkol. 2005; 9(9): 396–403 (in Polish).
19.
Makara-Studzińska M, Morylowska-Topolska J, Sygit K, Sygit M, Goździewska M. Socio-demographical and psychosocial determinants of anxiety symptoms in a population of pregnant women in the regions of central and eastern Poland. Ann Agric Environ Med. 2013; 20(1): 195–202.
20.
Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai. 2007; 90(10): 2164–2174.
21.
Burris JL, Andrykowski M. Disparities in mental health between rural and nonrural cancer survivors: a preliminary study. Psychooncology 2010; 19(6): 637–645.
22.
Weaver KE, Geiger AM, Lu L, Case LD. Rural-urban disparities in health status among US cancer survivors. Cancer 2013; 119(5): 1050–1057.
23.
Lim CC, Devi MK, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011; 9(3): 215–235.
24.
Zegarski W, Głowacka I, Ostrowska Ż. Ocena jakości życia kobiet po mastektomii na podstawie standardowych kwestionariuszy: QLQ-C30 i QLQ-BR23. Nowotwory. 2010; 60(6): 532–535 (in Polish).
25.
Juszczyński Z. Narzędzia pomiaru w promocji i psychologii zdrowia. Warszawa, Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, 2001 (in Polish).
Share
RELATED ARTICLE
| eISSN: | 1898-2263 |
| ISSN: | 1232-1966 |
Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.
Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
© 2006-2024 Journal hosting platform by Bentus
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
